Clinical Trial Update: Intermediate Size Patient Population Expanded Access IND for the Treatment of Patients With Parkinson's Disease.

View source ↗

Summary

An Expanded Access IND for Parkinson's disease with an intermediate-size patient population is no longer available.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Parkinson Disease

Snippet

Sponsor: Hope Biosciences Research Foundation | Conditions: Parkinson Disease | Status: NO_LONGER_AVAILABLE